Rchr
J-GLOBAL ID：201901014774258333   Update date: Nov. 25, 2024

Yamamoto Kenji

Yamamoto Kenji
Affiliation and department：
National Hospital Organization Minami Kyoto Hospital Department of Neurology / Department of Clinical Research

About National Hospital Organization Minami Kyoto Hospital Department of Neurology / Department of Clinical Research


Job title： Director
Research field  (2)： Neuroscience - general ,  Neurology
Research keywords  (10)： Alzheimer's disease ,  amyloid β ,  amyloid precursor protein ,  α-synuclein ,  oligomer ,  patch clump ,  dopamine ,  Parkinson's disease ,  calcium ,  neurodegeneration
Research theme for competitive and other funds  (4)：
  • 2020 - 2023 The analysis of aberrant machinery mediated by intraneural and extraneural alpha-synuclein oilgomers
  • 2014 - 2017 The neuronal dysfunction by alpha-synuclein oligomers in Parkinson's disease
  • 2011 - 2014 The analysis of abnormal neuronal excitability mediated by alpha-synuclein oligomer
  • 2007 - 2009 Relationship between neuronal death and inclusion body formation
Papers (46)：
  • Masayuki Tahara, Tomoko Oeda, Kazumasa Okada, Kazuhide Ochi, Hirofumi Maruyama, Hikoaki Fukaura, Kyoichi Nomura, Yuko Shimizu, Ichiro Nakashima, Tatsuro Misu, et al. Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration. Multiple Sclerosis and Related Disorders. 2022. 60. 103730-103730
  • Kenji Yamamoto. Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease. Archives of Pharmacal Research. 2021
  • Kenji Yamamoto, Ryo Yamamoto, Nobuo Kato. Amyloid β and Amyloid Precursor Protein Synergistically Suppress Large-Conductance Calcium-Activated Potassium Channel in Cortical Neurons. Frontiers in Aging Neuroscience. 2021. 13
  • Kazuyuki Togo, Toshiya Ishihara, Kenji Yamamoto, Hideyuki Sawada. Older-onset levodopa-responsive parkinsonism with normal DAT-SPECT and pterin hypometabolism. BMJ Case Reports. 2021. 14. 5. e240067-e240067
  • Hideyuki Sawada, Tomoko Oeda, Masayuki Kohsaka, Satoshi Tomita, Atsushi Umemura, Kwiyoung Park, Kenji Yamamoto, Kosuke Kiyohara. Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial. Expert opinion on pharmacotherapy. 2020. 22. 3. 1-9
ｍore...
MISC (7)：
ｍore...
Lectures and oral presentations  (225)：
  • 血管炎性ニューロパチーの末梢神経組織におけるgalectin-10の分布の検討
    (末梢神経 2023)
  • アセタゾラミドが著効した前頭葉てんかんの1例
    (神経治療学 2023)
  • パーキンソン病の臨床マイルストーンと生命予後との関係
    (国立病院総合医学会講演抄録集 2023)
  • レボドパ/カルビドパ配合経腸用液治療における午後の運動症状悪化とレボドパ薬物動態
    (国立病院総合医学会講演抄録集 2023)
  • アセタゾラミドadd-on治療が有効であった薬剤難治てんかんの一例
    (国立病院総合医学会講演抄録集 2023)
ｍore...
Education (1)：
  • 1997 - 2001 Graduate School of Medicine, Kyoto University, Department of Neurology/Integrative Brain Science,
Professional career (1)：
  • MD, PhD (Kyoto University)
Work history (6)：
  • 2023 - 現在 National Hospital Organization Miami Kyoto Hospital Department of Neurology / Department of Clinical Research Director of Clinical Research
  • 2016 - 2023 National Hospital Organization Utano National Hospital, Department of Neurology and Clinical Research Center, Consultant
  • 2009 - 2023 National Hospital Organization Utano National Hospital, Department of Neurology and Clinical Research Center, Laboratory Head of physiology
  • 2006 - 2016 National Hospital Organization Utano National Hospital, Department of Neurology and Clinical Research Center head physician
  • 2003 - 2005 Kyoto University Hospital Department of Neurology, medical stuff
Show all
Association Membership(s) (7)：
日本認知症学会 ,  日本パーキンソン病・運動障害疾患学会 ,  Society for Neuroscience ,  THE PHYSIOLOGICAL SOCIETY OF JAPAN ,  THE JAPAN NEUROSCIENCE SOCIETY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  JAPANESE SOCIETY OF NEUROLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM